Filter Search


Europe


Location Summary Deadline
Germany Pharmaceutical Discount Agreements From 01.12.2024 For Various Active Ingredients Within The Framework Of An Open-house Procedure 2026-10-01
Finland Veikkaus Oy Research Services 2026-10-03
Germany Dynamic Purchasing System For Offsetting The Ecb’s Greenhouse Gas Emissions 2026-10-03
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Erythropoietin (exclusively Epoetin Zeta), (obo), Atc B03xa01 For The Period 01.12.2024 - 30.11.2026 2026-10-05
Germany Open House Drug Discount Agreements Flupentixol, Atc N05af01 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Elafibranor (obo), Atc A05ax06 For The Period 01.12.2024 30.11.2026 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Elafibranor (obo), Atc A05ax06 For The Period 01.12.2024 - 30.11.2026 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Dihydrocodeine (obg), Atc R05da14 For The Period 01.12.2024 - 30.11.2026 2026-10-05
Lithuania Purchase Of Vehicle Operating Leases 2026-10-05
Germany Open House Drug Rebate Agreements Bosutinib, Atc L01ea04 2026-10-05
Whats app